Its potential clinical use in the therapeutic decision making process is substantiated by a vast body of literature validating variations in serum 100B levels with standard modalities for prognosticating the extent of CNS damage: alterations in neuroimaging, cerebrospinal pressure, and other brain molecular markers (neuron specific enolase, glial fibrillary acidic protein) [11], [12].
TBI also induces mechanical damage, excitotoxic damage, alterations in Ca+ homeostasis, and mitochondrial dysfunction, resulting in brain edema [ 17, 18].
Several factors have been suggested to be involved like vascular damage, alterations in platelet aggregation, and hypomagnesemia [ 72].
In conclusion, in this animal model of diffuse alveolar damage, alterations in host serum magnesium levels may modulate the degree of lung damage.
It further mimics the clinical presentation of signs and symptoms observed in FMS with widespread hyperalgesia, minimal muscle tissue damage, alterations in central nociceptive processing, and alterations in cardiovascular autonomic balance.
The combination of hyperglycemia, insulin resistance, dyslipidemia, hypertension, and chronic inflammation injures the vascular endothelium, resulting in microvascular damage (alterations in capillary density and vascular permeability), macrovasculopathy, and CVD.
Reduced peroxisomal functions may enhance progression of pre-tangle formation and further accelerate pathological processes including mitochondrial damage, alterations in the endosomal lysosomal system, ER-stress and finally neuronal death.
Bronchiectasis is a progressive respiratory disease characterized by repeated lower respiratory tract infections and an intense inflammatory response leading to tissue damage, alterations to lung structure, and premature death in adulthood (Barker 2002).
This "scattered type" staining of p53 may rather reflect an accumulation of wild-type p53 protein as a result of either a response to DNA damage, alterations in the normal degradation process, or the stabilization of the gene product by an interaction with viral or cellular proteins 34, 35.
